These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 15647980)
1. [The management of dysphagia -- part 2: therapy]. Schönweiler R; Raap M Laryngorhinootologie; 2005 Jan; 84(1):55-62; quiz 63-6. PubMed ID: 15647980 [TBL] [Abstract][Full Text] [Related]
2. [The management of Dysphagia. Part 1: diagnostics]. Schönweiler R Laryngorhinootologie; 2004 Dec; 83(12):862-70; quiz 871-4. PubMed ID: 15611909 [TBL] [Abstract][Full Text] [Related]
3. Long-lasting effect of a single botulinum toxin injection in the treatment of oropharyngeal dysphagia secondary to upper esophageal sphincter dysfunction: a pilot study. Terre R; Valles M; Panades A; Mearin F Scand J Gastroenterol; 2008; 43(11):1296-303. PubMed ID: 18649151 [TBL] [Abstract][Full Text] [Related]
4. Management of cricopharyngeus muscle dysfunction. Kuhn MA; Belafsky PC Otolaryngol Clin North Am; 2013 Dec; 46(6):1087-99. PubMed ID: 24262961 [TBL] [Abstract][Full Text] [Related]
5. [A retrospective study of 91 injections of botulinus toxin into the upper sphincter of the oesophagus]. Verhulst J; Amé P; Guatterie M; Barat M; Traissac L Rev Laryngol Otol Rhinol (Bord); 2003; 124(5):315-20. PubMed ID: 15144028 [TBL] [Abstract][Full Text] [Related]
6. Improving care for patients with dysphagia. Rosenvinge SK; Starke ID Age Ageing; 2005 Nov; 34(6):587-93. PubMed ID: 16267184 [TBL] [Abstract][Full Text] [Related]
7. Dysphagia associated with cricopharyngeal dysfunction. Schultz AR; Niemtzow P; Jacobs SR; Naso F Arch Phys Med Rehabil; 1979 Aug; 60(8):381-6. PubMed ID: 464785 [TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin treatment for oropharyngeal dysphagia associated with diabetic neuropathy. Restivo DA; Marchese-Ragona R; Lauria G; Squatrito S; Gullo D; Vigneri R Diabetes Care; 2006 Dec; 29(12):2650-3. PubMed ID: 17130199 [TBL] [Abstract][Full Text] [Related]
9. Botulinum neurotoxin for management of intractable central leakage through a voice prosthesis in surgical voice restoration. Mullan GP; Lee MT; Clarke PM J Laryngol Otol; 2006 Sep; 120(9):789-92. PubMed ID: 16859568 [TBL] [Abstract][Full Text] [Related]
10. The role of speech language pathologists in the management of dysphagia, 1989. Erlichman M Health Technol Assess Rep; 1989; (1):1-10. PubMed ID: 2697321 [TBL] [Abstract][Full Text] [Related]
11. [Neurogenic dysphagia: physiology, physiopathology and rehabilitative treatment]. Patti F; Emmi N; Restivo DA; Liberto A; Pappalardo A; Torre LM; Reggio A Clin Ter; 2002; 153(6):403-19. PubMed ID: 12645398 [TBL] [Abstract][Full Text] [Related]
12. The role of the speech language pathologist in the management of dysphagia. Logemann JA Otolaryngol Clin North Am; 1988 Nov; 21(4):783-8. PubMed ID: 3054726 [TBL] [Abstract][Full Text] [Related]
19. Ultrasonography-guided botulinum toxin injection to the cricopharyngeus muscle: a case report and technical notes. Wang YC; Wu CH; Shyu SG; Hsiao MY; Wang TG Med Ultrason; 2020 Sep; 22(3):345-355. PubMed ID: 32190858 [TBL] [Abstract][Full Text] [Related]
20. Effects of the head lift exercise on the swallow function: a systematic review. Antunes EB; Lunet N Gerodontology; 2012 Dec; 29(4):247-57. PubMed ID: 22612867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]